WS #11608
FDA grants accelerated approval for Vera Therapeutics' Trutakna for IgA nephropathy, a significant biotech catalyst for VERA. New York Fed survey shows Americans' inflation expectations rose in June, driven by medical care and rent, adding to macro headwinds.
Vera Therapeutics FDA Approval
FDA grants accelerated approval for Vera Therapeutics' Trutakna for IgA nephropathy, a significant biotech catalyst for VERA.
New York Fed survey shows Americans' inflation expectations rose in June, driven by medical care and rent, adding to macro headwinds.